Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Management

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Management
  • News

Harmony Biosciences Announces Jeffrey M. Dayno, M.D. Appointed President & Chief Executive Officer

By Happy Mohamed
April 24, 8:26 AM
Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ:HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare

HRMY

Read More
1 minute read
  • Management
  • News

Butterfly Network’s Board Approves Appointment Of Joseph DeVivo As CEO And Chair, Effective as of April 24

By Benzinga Newsdesk
April 24, 8:10 AM
On April 19, 2023, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Butterfly Network, Inc. (the “Company”), the Board

BFLY

Read More
1 minute read
  • Equities
  • Guidance
  • Management
  • Markets
  • News

Waste Connections Reappoints Ronald Mittelstaedt As CEO; Reaffirms FY23 Guidance

By Akanksha Bakshi
April 24, 7:34 AM
Waste Connections, Inc (NYSE:WCN) has named the Executive Chairman, Ronald J. Mittelstaedt, as its President and Chief Executive Officer,…

WCN

Read More
2 minute read
  • General
  • Management
  • News
  • Social Media

‘You’ve Shattered The Morale,’ Meta Employee Demands Answers From Zuckerberg, Questions Reasons To Stay, CEO Responds

By Chris Katje
April 21, 4:24 PM
Technology and social media company Meta Platforms (NASDAQ: META) has made headlines for layoff announcements and rumors over the last year. The company recently held a town hall to share updates and answer direct questions from employees.

META

Read More
1 minute read
  • Management
  • Media
  • News
  • Tech

Professor Jack Ma: Alibaba Honcho Accepts Hong Kong University’s Honorary Position

By Anusuya Lahiri
April 21, 12:42 PM
Alibaba Group Holding Limited (NYSE:BABA)  co-founder and former chairman Jack Ma accepted the role of honorary professor at the University of…

BABA

Read More
2 minute read
  • Management
  • Media
  • News
  • Tech
  • Top Stories

Meta’s Townhall: Mark Zuckerberg Updates On Layoffs, Hiring and Incentives

By Anusuya Lahiri
April 21, 8:17 AM
Meta Platforms, Inc (NASDAQ: META) CEO Mark Zuckerberg told employees that he would not rule out future layoffs and does not expect the social-media company to hire as quickly as before in a virtual Q&A session Thursday, a day after the company completed its 

META

Read More
2 minute read
  • Cannabis
  • Contracts
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Rumors
  • Top Stories

Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off

By Lara Goldstein
April 20, 2:48 PM
Monash University Engages LaNeo MDMA Australian Monash University’s psychedelics research lab has contracted MDXX-class molecules developer PharmAla Biotech to manufacture and supply its clinical-grade MDMA LaNeo for an upcoming Phase 2 clinical study. 

CMND

Read More
2 minute read
  • Cannabis
  • Contracts
  • General
  • Health Care
  • Legal
  • M&A
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Top Stories

Psyched Business: Lobe Buys Rare Disease Treatment, Plus Healing CREI And Heally Team Up

By Lara Goldstein
April 20, 2:24 PM
Orphan and rare diseases drug company Lobe Sciences Ltd. (OTCQB: LOBEF) is set to acquire Altemia & Company LLC.

LOBEF

Read More
3 minute read
  • Management
  • News
  • Small Cap
  • Top Stories

CEO Who Told Employees To Leave ‘Pity City’ Offers Apology For ‘Rallying Cry,’ Employees Tell Media They Face Termination If They Discuss

By Chris Katje
April 20, 1:18 PM
A video of a CEO criticizing employees for worrying about their bonuses quickly went viral. Here’s an update on the story including comments from employees to local media.

MLKN

Read More
1 minute read
  • Equities
  • General
  • Management
  • Markets
  • Movers
  • News

Why LTL Freight Transportation Company XPO’s Shares Are Jumping Today

By Shivani Kumaresan
April 20, 11:38 AM
Freight transportation company XPO Inc (NYSE:XPO) is jumping over 14% Thursday morning. The company disclosed in a regulatory filing that it is…

ODFL

Posts pagination

Previous 1 … 207 208 209 … 341 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service